2',3'-Bis(O-(t-butyldimethylsilyl)-5-methoxyuridine

2',3'-Bis(O-(t-butyldimethylsilyl)-5-methoxyuridine Suppliers list

Company Name:	Zhengzhou Granlen Sciences, ltd.
Tel:	0371-85513397 +86-18610099868
Email:	info@granlen.com

Company Name:	SHANGHAI T&W PHARMACEUTICAL CO., LTD.
Tel:	+86-021-61551413
Email:	contact@trustwe.com

Company Name:	Xi'an Kezhan Biotechnology Co., Ltd.
Tel:	18729005399
Email:	78282739@qq.com

2',3'-Bis(O-(t-butyldimethylsilyl)-5-methoxyuridine manufacturers

2',3'-Bis(O-(t-butyldimethylsilyl)-5-methoxyuridine Basic information

Product Name:	2',3'-Bis(O-(t-butyldimethylsilyl)-5-methoxyuridine
Synonyms:	2',3'-Bis(O-(t-butyldimethylsilyl)-5-methoxyuridine;2’,3’-Bis(O-(t-butyldimethylsilyl)-5-methoxyuridine
CAS:	2305415-94-3
MF:	C22H42N2O7Si2
MW:	502.76
EINECS:
Product Categories:
Mol File:	2305415-94-3.mol

2',3'-Bis(O-(t-butyldimethylsilyl)-5-methoxyuridine Chemical Properties

density	1.12±0.1 g/cm3(Predicted)
pka	8+-.0.10(Predicted)

Safety Information

MSDS Information

2',3'-Bis(O-(t-butyldimethylsilyl)-5-methoxyuridine Usage And Synthesis

Uses	2’,3’-Bis(O-(t-butyldimethylsilyl)-5-methoxyuridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
References	[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005

2',3'-Bis(O-(t-butyldimethylsilyl)-5-methoxyuridine Preparation Products And Raw materials

Tag:2',3'-Bis(O-(t-butyldimethylsilyl)-5-methoxyuridine(2305415-94-3) Related Product Information

3'-O-(t-Butyldimethylsilyl)-2'-O-(2-methoxyethyl) uridine 3'-O-(t-Butyldimethylsilyl)-2'-O-methyluridine Uridine, 3',5'-bis-O-[(1,1-dimethylethyl)dimethylsilyl]-2'-O-methyl- 5-Chloro-2'-deoxyuridine Uridine Capecitabine